Don't have an account? To participate in discussions consider signing up or signing in
facebook connect
Sign-up, its free! Close [x]


  • okay Create lasting relationships with other like minded women.
  • okay Blogging, let your voice be heard!
  • okay Interact with other women through blogs,questions and groups.
  • okay Photo Album, upload your most recent vacation pictures.
  • okay Contests, Free weekly prize drawing.
  • okay Weekly Newsletter.

!pic(image description)!
Weeks ago, the US Food and Drug Administration (FDA) opened an inquiry into the safety of botulinum toxin products, after receiving reports of breathing difficulties and deaths of patients using both Botox and a competing product, Myobloc. A small number of these adverse events involved children with cerebral palsy who were being treated for muscle spasms associated with the disorder, an unapproved use of either product.

Botox as most of us know, is more popularly used as an injectable cosmetic treatment to temporarily erase wrinkles for three or four months. It works by blocking overactive nerve impulses, thereby decreasing muscle activity.

Allergan, the makers of Botox, say that the adverse events being investigated by FDA all occurred in patients using the drug as part of aggressive, high-dose neuromuscular treatments and not for cosmetic treatment.  

What’s interesting to note is that although Allergan’s stock dropped by 6% with the FDA announcement, it has since recovered. And analysts agree that the FDA’s announcement is not likely to have any impact on Allergan’s share price.

Is this telling us that women (and men) are more concerned about the benefits of Botox versus its potential risk? What do you think?

Sharmani Pillay is a Registered Pharmacist who specializes in anti aging skin care and wellness issues that women over 40 face. She operates an online anti aging skin store at [Link Removed] 

Pharmagirl, Your links have been removed, please consider upgrading to premium membership.


Member Comments

About this author View Blog »